{
    "hands_on_practices": [
        {
            "introduction": "The DNA sequence itself provides crucial clues about the landscape of epigenetic regulation. This exercise guides you through building a predictive model for CpG islands, which are genomic regions typically protected from DNA methylation. By applying Bayes' theorem, you will derive a probabilistic classifier from first principles, learning how fundamental sequence features like GC content and CpG density can be used to estimate a region's methylation susceptibility. This practice is fundamental to computational epigenomics, connecting primary DNA information to higher-order regulatory states. ",
            "id": "4335581",
            "problem": "A central phenomenon in systems biomedicine is that Deoxyribonucleic Acid (DNA) cytosine methylation is depleted within Cytosine-phosphate-Guanine (CpG) islands, which are short genomic regions characterized by high Guanine + Cytosine (GC) content and elevated CpG observed/expected values relative to the genomic background. Let a genomic window of length $L$ be summarized by two sequence features: GC content $g$ defined as $g = (n_{G} + n_{C})/L$, and the CpG observed/expected ratio $r$ defined as $r = \\dfrac{n_{\\mathrm{CpG}} \\cdot L}{n_{C} \\cdot n_{G}}$, where $n_{G}$, $n_{C}$, and $n_{\\mathrm{CpG}}$ are the counts of guanine, cytosine, and CpG dinucleotides within the window, respectively. We consider a probabilistic, sequence-only classifier that predicts CpG island presence and, by complement, methylation susceptibility.\n\nAssume there are two latent classes: island ($I$) and non-island ($N$). Conditional on the class, the features are independent and Gaussian: $g \\mid I \\sim \\mathcal{N}(\\mu_{g,I}, \\sigma_{g,I}^{2})$, $r \\mid I \\sim \\mathcal{N}(\\mu_{r,I}, \\sigma_{r,I}^{2})$, $g \\mid N \\sim \\mathcal{N}(\\mu_{g,N}, \\sigma_{g,N}^{2})$, and $r \\mid N \\sim \\mathcal{N}(\\mu_{r,N}, \\sigma_{r,N}^{2})$. Let the prior probability of the island class be $\\pi = \\mathbb{P}(I)$, so that $\\mathbb{P}(N) = 1 - \\pi$. Here $\\mu_{g,I}$, $\\sigma_{g,I}$, $\\mu_{r,I}$, $\\sigma_{r,I}$, $\\mu_{g,N}$, $\\sigma_{g,N}$, $\\mu_{r,N}$, $\\sigma_{r,N}$, and $\\pi$ are fixed parameters representing a genomic context and species.\n\nStarting only from the definitions of $g$ and $r$, the independence assumption, the Gaussian likelihood, and Bayes’ theorem, derive the analytic expression for the methylation susceptibility $S(g,r)$ of the window, defined as $S(g,r) = 1 - \\mathbb{P}(I \\mid g, r)$, under this model. Express your final answer as a single closed-form function of $g$, $r$, $\\mu_{g,I}$, $\\sigma_{g,I}$, $\\mu_{r,I}$, $\\sigma_{r,I}$, $\\mu_{g,N}$, $\\sigma_{g,N}$, $\\mu_{r,N}$, $\\sigma_{r,N}$, and $\\pi$. No numerical evaluation is required. Give your final expression in simplest form with standard elementary functions. State your final answer as one analytic expression; no inequalities or equations are permitted within the final answer.",
            "solution": "The problem statement is evaluated as scientifically grounded, well-posed, and objective. It provides a complete and consistent set of definitions and conditions for a standard problem in probabilistic classification. The model, while an abstraction, is based on established principles in computational biology and statistical modeling. Therefore, the problem is valid, and a solution can be derived.\n\nThe methylation susceptibility, $S(g,r)$, is defined as $S(g,r) = 1 - \\mathbb{P}(I \\mid g, r)$, where $I$ denotes the CpG island class and $(g, r)$ are the observed features (GC content and CpG ratio). Since the latent classes are island ($I$) and non-island ($N$), the law of total probability for conditional probabilities states that $\\mathbb{P}(I \\mid g, r) + \\mathbb{P}(N \\mid g, r) = 1$. Thus, the susceptibility is precisely the posterior probability of the non-island class given the data:\n$$\nS(g,r) = \\mathbb{P}(N \\mid g, r)\n$$\nTo find this posterior probability, we apply Bayes' theorem. Let $p(\\cdot)$ denote a probability density function.\n$$\n\\mathbb{P}(N \\mid g, r) = \\frac{p(g, r \\mid N) \\mathbb{P}(N)}{p(g, r)}\n$$\nThe denominator, $p(g,r)$, is the marginal probability of the data, which can be expanded using the law of total probability over the two latent classes:\n$$\np(g, r) = p(g, r \\mid I) \\mathbb{P}(I) + p(g, r \\mid N) \\mathbb{P}(N)\n$$\nSubstituting this into the expression for the posterior gives:\n$$\n\\mathbb{P}(N \\mid g, r) = \\frac{p(g, r \\mid N) \\mathbb{P}(N)}{p(g, r \\mid I) \\mathbb{P}(I) + p(g, r \\mid N) \\mathbb{P}(N)}\n$$\nTo simplify this expression, we can divide the numerator and the denominator by the term $p(g, r \\mid N) \\mathbb{P}(N)$:\n$$\nS(g, r) = \\frac{1}{\\frac{p(g, r \\mid I) \\mathbb{P}(I)}{p(g, r \\mid N) \\mathbb{P}(N)} + 1}\n$$\nThe problem states that, conditional on the class, the features $g$ and $r$ are independent. This allows us to write the joint conditional likelihoods as the product of the individual conditional likelihoods:\n$$\np(g, r \\mid I) = p(g \\mid I) p(r \\mid I)\n$$\n$$\np(g, r \\mid N) = p(g \\mid N) p(r \\mid N)\n$$\nThe prior probabilities are given as $\\mathbb{P}(I) = \\pi$ and $\\mathbb{P}(N) = 1 - \\pi$. The ratio in the denominator becomes:\n$$\n\\frac{p(g \\mid I) p(r \\mid I) \\pi}{p(g \\mid N) p(r \\mid N) (1 - \\pi)}\n$$\nThe conditional distributions are given as Gaussian. The probability density function for a normal distribution $\\mathcal{N}(\\mu, \\sigma^2)$ is $p(x) = \\frac{1}{\\sqrt{2\\pi}\\sigma} \\exp\\left(-\\frac{(x - \\mu)^2}{2\\sigma^2}\\right)$. We substitute the corresponding PDFs for each term:\n\\begin{itemize}\n    \\item $p(g \\mid I) = \\frac{1}{\\sqrt{2\\pi}\\sigma_{g,I}} \\exp\\left(-\\frac{(g - \\mu_{g,I})^2}{2\\sigma_{g,I}^2}\\right)$\n    \\item $p(r \\mid I) = \\frac{1}{\\sqrt{2\\pi}\\sigma_{r,I}} \\exp\\left(-\\frac{(r - \\mu_{r,I})^2}{2\\sigma_{r,I}^2}\\right)$\n    \\item $p(g \\mid N) = \\frac{1}{\\sqrt{2\\pi}\\sigma_{g,N}} \\exp\\left(-\\frac{(g - \\mu_{g,N})^2}{2\\sigma_{g,N}^2}\\right)$\n    \\item $p(r \\mid N) = \\frac{1}{\\sqrt{2\\pi}\\sigma_{r,N}} \\exp\\left(-\\frac{(r - \\mu_{r,N})^2}{2\\sigma_{r,N}^2}\\right)$\n\\end{itemize}\nLet's compute the likelihood ratio $p(g, r \\mid I) / p(g, r \\mid N)$:\n$$\n\\frac{p(g, r \\mid I)}{p(g, r \\mid N)} = \\frac{\\frac{1}{2\\pi\\sigma_{g,I}\\sigma_{r,I}} \\exp\\left(-\\frac{(g - \\mu_{g,I})^2}{2\\sigma_{g,I}^2} - \\frac{(r - \\mu_{r,I})^2}{2\\sigma_{r,I}^2}\\right)}{\\frac{1}{2\\pi\\sigma_{g,N}\\sigma_{r,N}} \\exp\\left(-\\frac{(g - \\mu_{g,N})^2}{2\\sigma_{g,N}^2} - \\frac{(r - \\mu_{r,N})^2}{2\\sigma_{r,N}^2}\\right)}\n$$\nThe $1/(2\\pi)$ terms cancel. We can combine the constant prefactors and the exponential terms:\n$$\n\\frac{p(g, r \\mid I)}{p(g, r \\mid N)} = \\frac{\\sigma_{g,N}\\sigma_{r,N}}{\\sigma_{g,I}\\sigma_{r,I}} \\exp\\left[ \\left(-\\frac{(g - \\mu_{g,I})^2}{2\\sigma_{g,I}^2} - \\frac{(r - \\mu_{r,I})^2}{2\\sigma_{r,I}^2}\\right) - \\left(-\\frac{(g - \\mu_{g,N})^2}{2\\sigma_{g,N}^2} - \\frac{(r - \\mu_{r,N})^2}{2\\sigma_{r,N}^2}\\right) \\right]\n$$\nRearranging the terms inside the exponent for clarity:\n$$\n\\text{Exponent} = \\frac{(g - \\mu_{g,N})^2}{2\\sigma_{g,N}^2} - \\frac{(g - \\mu_{g,I})^2}{2\\sigma_{g,I}^2} + \\frac{(r - \\mu_{r,N})^2}{2\\sigma_{r,N}^2} - \\frac{(r - \\mu_{r,I})^2}{2\\sigma_{r,I}^2}\n$$\nNow, we assemble the full expression for $S(g,r)$:\n$$\nS(g,r) = \\left(1 + \\frac{\\pi}{1-\\pi} \\frac{p(g, r \\mid I)}{p(g, r \\mid N)}\\right)^{-1}\n$$\nSubstituting the likelihood ratio expression derived above yields the final analytical form for the methylation susceptibility:\n$$\nS(g,r) = \\left(1 + \\frac{\\pi}{1-\\pi} \\frac{\\sigma_{g,N}\\sigma_{r,N}}{\\sigma_{g,I}\\sigma_{r,I}} \\exp\\left( \\frac{(g - \\mu_{g,N})^2}{2\\sigma_{g,N}^2} - \\frac{(g - \\mu_{g,I})^2}{2\\sigma_{g,I}^2} + \\frac{(r - \\mu_{r,N})^2}{2\\sigma_{r,N}^2} - \\frac{(r - \\mu_{r,I})^2}{2\\sigma_{r,I}^2} \\right)\\right)^{-1}\n$$\nThis expression is a single closed-form function of the given features ($g, r$) and model parameters ($\\pi$, $\\mu_{g,I}$, $\\sigma_{g,I}$, $\\mu_{r,I}$, $\\sigma_{r,I}$, $\\mu_{g,N}$, $\\sigma_{g,N}$, $\\mu_{r,N}$, $\\sigma_{r,N}$), as required.",
            "answer": "$$\\boxed{\\left(1 + \\frac{\\pi}{1-\\pi} \\frac{\\sigma_{g,N}\\sigma_{r,N}}{\\sigma_{g,I}\\sigma_{r,I}} \\exp\\left( \\frac{(g - \\mu_{g,N})^2}{2\\sigma_{g,N}^2} - \\frac{(g - \\mu_{g,I})^2}{2\\sigma_{g,I}^2} + \\frac{(r - \\mu_{r,N})^2}{2\\sigma_{r,N}^2} - \\frac{(r - \\mu_{r,I})^2}{2\\sigma_{r,I}^2} \\right)\\right)^{-1}}$$"
        },
        {
            "introduction": "Designing informative experiments is as critical as analyzing the data they produce. This practice places you in the role of an experimental designer tasked with planning a whole-genome bisulfite sequencing (WGBS) study. You will perform a power calculation to determine the minimum sequencing coverage required to reliably detect a specific change in DNA methylation between two conditions. This exercise builds essential biostatistical intuition, demonstrating how to use foundational principles of sampling variance to ensure an experiment is adequately powered to answer a biological question. ",
            "id": "4335603",
            "problem": "A Whole-Genome Bisulfite Sequencing (WGBS) experiment is designed to compare mean DNA methylation across a single CpG island of length $L = 10{,}000$ base pairs in two biological conditions. The region’s CpG density is $d = 0.01$ CpG sites per base pair, so the total number of CpG sites is $m = dL$. In each condition, the average per-base sequencing depth over the region is $D$, and you may assume that for each CpG site, the expected coverage equals this average depth, so the per-site coverage is $c = D$ in each condition.\n\nAssume the following foundational framework:\n- At each CpG site, methylation read counts arise from independent Bernoulli trials with true methylation fraction $p$, and the number of trials equals the per-site coverage $c$. Thus, the per-site methylation fraction estimator is the sample proportion from a binomial process.\n- The per-site estimators are independent across CpG sites within the region (justified by the assumption that local correlations are negligible at the scale of the region-level mean).\n- To be conservative with respect to sampling variance, treat the baseline methylation fraction as $p = 0.5$, which maximizes binomial variance.\n- Use the normal approximation to the binomial to approximate the sampling distribution of the average methylation fraction across sites in each condition, and use the normal approximation for the difference of two independent sample means.\n- The detection target is a true difference in mean methylation across the region of $\\Delta = 0.05$ between the two conditions.\n\nDefine the two-sided confidence criterion as requiring that the standardized difference between the two sample means has magnitude at least the standard normal critical value for a $95\\%$ confidence level, that is $z^{\\star} = 1.96$.\n\nUsing only the assumptions above and well-tested facts about binomial sampling and normal approximations, determine the minimum total number of methylation-informative reads across the CpG island required per condition to meet the $95\\%$ confidence criterion for detecting the difference $\\Delta$. Your final answer must be a single real number equal to the required total read count per condition. Express your answer as an exact real number (dimensionless count of reads); do not round.",
            "solution": "The user has submitted a problem for validation and solution.\n\n### Step 1: Extract Givens\n- CpG island length: $L = 10,000$ base pairs\n- CpG density: $d = 0.01$ CpG sites per base pair\n- Total number of CpG sites: $m = dL$\n- Per-site coverage in each condition: $c$\n- Methylation at each site modeled by independent Bernoulli trials with true methylation fraction $p$.\n- Number of trials per site equals coverage $c$.\n- Per-site methylation fraction estimator is the sample proportion from a binomial process.\n- Per-site estimators are independent across CpG sites.\n- Baseline methylation fraction for variance calculation: $p = 0.5$.\n- Normal approximation to the binomial and for the difference of two sample means is to be used.\n- Target true difference in mean methylation: $\\Delta = 0.05$.\n- Detection criterion: The standardized difference between the two sample means has magnitude at least the standard normal critical value for a $95\\%$ confidence level, $z^{\\star} = 1.96$.\n- The goal is to find the minimum total number of methylation-informative reads across the CpG island required per condition.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed against the required criteria.\n- **Scientifically Grounded**: The problem is well-grounded in the biostatistics of sequencing data analysis. It uses a standard binomial model for methylation counts and the normal approximation, which is appropriate for power/sample size calculations. The use of $p=0.5$ for variance maximization is a standard conservative approach in experimental design.\n- **Well-Posed**: The problem is well-posed. It specifies a clear objective (calculate minimum total reads) and provides all necessary parameters, models, and assumptions to arrive at a unique mathematical solution.\n- **Objective**: The problem is stated in precise, objective, and quantitative terms. It is free from subjective or ambiguous language.\n- **Completeness and Consistency**: The problem is self-contained and internally consistent. The provided values for $L$ and $d$ are used to define $m$, and all assumptions form a coherent framework for solving the problem. There are no contradictions.\n\n### Step 3: Verdict and Action\nThe problem is **valid**. Proceeding to the solution.\n\nThe objective is to determine the minimum total number of reads required per condition to detect a specified difference in mean methylation with $95\\%$ confidence. Let $R$ be the total number of methylation-informative reads across the CpG island per condition.\n\nFirst, we establish the statistical model. The region contains $m$ CpG sites. The number of reads at each site (coverage) is $c$. The total number of reads per condition is the sum of coverages over all sites, which is $R = m \\cdot c$.\n\nFor a single CpG site $j$ in a given condition, the number of methylated reads is binomially distributed. The estimator for the methylation fraction at this site, $\\hat{p}_j$, is the sample proportion of methylated reads. Its variance is given by $\\text{Var}(\\hat{p}_j) = \\frac{p_j(1-p_j)}{c}$, where $p_j$ is the true methylation fraction at site $j$. To be conservative, we maximize this variance by setting $p_j = 0.5$, as specified in the problem.\n$$ \\text{Var}(\\hat{p}_j) = \\frac{0.5(1 - 0.5)}{c} = \\frac{0.25}{c} $$\nThis variance is the same for all sites under this conservative assumption.\n\nNext, we consider the mean methylation fraction across the entire CpG island for one condition. The estimator for this regional mean is $\\hat{P} = \\frac{1}{m} \\sum_{j=1}^{m} \\hat{p}_j$. Since the per-site estimators are assumed to be independent, the variance of the regional mean estimator is:\n$$ \\text{Var}(\\hat{P}) = \\text{Var}\\left(\\frac{1}{m} \\sum_{j=1}^{m} \\hat{p}_j\\right) = \\frac{1}{m^2} \\sum_{j=1}^{m} \\text{Var}(\\hat{p}_j) $$\nSubstituting the per-site variance:\n$$ \\text{Var}(\\hat{P}) = \\frac{1}{m^2} \\sum_{j=1}^{m} \\frac{0.25}{c} = \\frac{1}{m^2} \\cdot m \\cdot \\frac{0.25}{c} = \\frac{0.25}{mc} $$\nThe total number of reads per condition is $R = mc$. Therefore, the variance of the regional mean estimator can be expressed in terms of $R$:\n$$ \\text{Var}(\\hat{P}) = \\frac{0.25}{R} $$\nThis shows that the precision of the regional methylation estimate depends on the total number of reads, not on how they are distributed among sites (i.e., the specific values of $m$ and $c$).\n\nWe are interested in the difference between two conditions. Let $\\hat{P}_1$ and $\\hat{P}_2$ be the estimated regional mean methylation fractions for condition $1$ and condition $2$, respectively. The estimator for the difference is $\\hat{\\Delta} = \\hat{P}_1 - \\hat{P}_2$. As the samples from the two conditions are independent, the variance of the difference is the sum of their individual variances:\n$$ \\text{Var}(\\hat{\\Delta}) = \\text{Var}(\\hat{P}_1) + \\text{Var}(\\hat{P}_2) $$\nAssuming each condition receives the same total number of reads $R$, we have:\n$$ \\text{Var}(\\hat{\\Delta}) = \\frac{0.25}{R} + \\frac{0.25}{R} = \\frac{0.5}{R} $$\nThe standard deviation of the difference, also known as the standard error of the difference, is:\n$$ \\sigma_{\\hat{\\Delta}} = \\sqrt{\\frac{0.5}{R}} $$\nThe problem sets a detection criterion: the magnitude of the standardized difference must be at least $z^{\\star} = 1.96$. The standardized difference in this context is the ratio of the true effect size ($\\Delta$) to the standard error of its estimator ($\\sigma_{\\hat{\\Delta}}$). This is a common requirement in experimental design, linking the signal-to-noise ratio to a desired level of statistical certainty. To find the minimum required reads, we set this ratio equal to $z^{\\star}$:\n$$ \\frac{\\Delta}{\\sigma_{\\hat{\\Delta}}} = z^{\\star} $$\nWe are given the true difference to detect, $\\Delta = 0.05$, and the critical value $z^{\\star} = 1.96$. Substituting these values and the expression for $\\sigma_{\\hat{\\Delta}}$:\n$$ \\frac{0.05}{\\sqrt{\\frac{0.5}{R}}} = 1.96 $$\nNow, we solve for $R$, the minimum total number of reads per condition. First, rearrange the equation to isolate $R$:\n$$ \\sqrt{\\frac{R}{0.5}} = \\frac{1.96}{0.05} $$\n$$ \\sqrt{2R} = 39.2 $$\nSquare both sides to eliminate the square root:\n$$ 2R = (39.2)^2 $$\n$$ 2R = 1536.64 $$\nFinally, solve for $R$:\n$$ R = \\frac{1536.64}{2} $$\n$$ R = 768.32 $$\nThis result represents the minimum required number of methylation-informative reads per condition, treated as a continuous quantity consistent with the normal approximation model. The problem explicitly asks for a real number and not to round, so this is the final answer. The parameters $L$ and $d$ (which give $m=100$) are consistent with the problem setup but are not needed for calculating the final answer, as the required quantity is the total number of reads $R=mc$.",
            "answer": "$$ \\boxed{768.32} $$"
        },
        {
            "introduction": "A central challenge in systems biomedicine is distinguishing causal drivers of disease from passive biomarkers. While an epigenetic mark, like DNA methylation $M$ or a histone modification $H$, may be correlated with a phenotype $Y$, this association can be confounded by many unmeasured factors. This practice introduces you to Mendelian Randomization (MR), a powerful strategy that leverages genetic variants as instrumental variables to infer causality from observational data. By reasoning through a hypothetical causal model, you will evaluate different MR strategies and diagnose their potential pitfalls, developing critical thinking skills essential for making robust causal claims in human studies. ",
            "id": "4335638",
            "problem": "A research team in systems biomedicine aims to determine whether epigenetic marks causally influence a complex inflammatory phenotype. Let $M$ denote DNA methylation at a promoter CpG site near a cytokine gene, let $H$ denote histone H$3$ lysine $27$ acetylation (H$3$K$27$ac) at the same promoter, and let $Y$ denote a continuous inflammatory biomarker measured in plasma. Observational analyses in a cohort of size $n$ show that $M$ and $H$ are each correlated with $Y$. Let $U$ denote unmeasured factors such as smoking intensity, latent infection burden, and circulating immune cell-type composition. The team considers the following linear structural model as a starting point: \n- $M = \\alpha_{G_M} G_M + \\alpha_{U \\to M} U + \\varepsilon_M$,\n- $H = \\alpha_{G_H} G_H + \\alpha_{U \\to H} U + \\varepsilon_H$,\n- $Y = \\beta_M M + \\beta_H H + \\beta_U U + \\varepsilon_Y$,\nwhere $G_M$ is a cis-methylation quantitative trait locus (cis-meQTL) for $M$ and $G_H$ is a cis-histone quantitative trait locus (cis-hQTL) for $H$, $\\varepsilon_M$, $\\varepsilon_H$, and $\\varepsilon_Y$ are mean-zero errors, and all coefficients are finite constants. Assume that germline genotypes are assigned at conception according to Mendel’s laws and are fixed across the life course, and that the Central Dogma (DNA to RNA to protein) holds as a well-tested organizing principle for molecular flow. The team recognizes that correlation between $M$ or $H$ and $Y$ is not, in general, causation.\n\nFrom first principles of causal inference and genetics, explain why naive regression of $Y$ on $M$ (or $H$) may be biased, and evaluate instrumental-variable strategies that use genetic variants to identify a causal effect of $M$ and $H$ on $Y$. Consider the core instrumental variable assumptions of relevance, independence, and exclusion restriction, and the possibility of horizontal pleiotropy and linkage disequilibrium.\n\nWhich of the following strategies and claims are valid for identifying and diagnosing a causal effect of $M$ and/or $H$ on $Y$ in this setting? Select all that apply.\n\nA. Use a single cis-meQTL $G_M$ as an instrument for $M$ and estimate the causal effect of $M$ on $Y$ using a ratio estimator in a one-sample analysis, after verifying that $G_M$ is strongly associated with $M$ (e.g., $F$-statistic $> 10$), that $G_M$ is not associated with measured proxies for $U$, and that fine-mapping and colocalization indicate the same causal variant drives the $G_M$–$M$ and $G_M$–$Y$ associations; complement with sensitivity analyses for horizontal pleiotropy.\n\nB. Use a trans-expression quantitative trait locus (trans-eQTL) that broadly influences multiple genes as an instrument for $H$, because its widespread regulatory influence both strengthens the instrument and minimizes violation of the exclusion restriction by averaging effects across pathways.\n\nC. Adjust for measured confounders in a multiple regression of $Y$ on $M$ and $H$; with a sufficiently large $n$, any residual unmeasured confounding by $U$ is expected to be negligible, so the coefficient on $M$ can be interpreted as causal without instrumental variables.\n\nD. Implement two-sample Mendelian randomization combining summary statistics: obtain $\\widehat{\\beta}_{YG}$ from a genome-wide association study of $Y$ and $\\widehat{\\beta}_{MG}$ from an epigenome-wide association study of $M$ for the same cis-meQTL $G_M$, require high posterior probability of colocalization between $M$ and $Y$ at the locus, apply Steiger directionality to test $G_M \\to M \\to Y$, and restrict to ancestrally matched samples to mitigate population stratification.\n\nE. Construct a polygenic risk score for $Y$ and use it as an instrument for $M$ to maximize instrument strength; since germline variants are fixed, this will satisfy the independence assumption and thereby identify the causal effect of $M$ on $Y$.\n\nF. Fit a multivariable Mendelian randomization using $G_M$ as an instrument for $M$ and $G_H$ as an instrument for $H$ to estimate the direct effects $\\beta_M$ and $\\beta_H$ simultaneously; diagnose weak instruments with conditional $F$-statistics and assess directional pleiotropy using methods such as multivariable MR-Egger, while verifying that $G_M$ and $G_H$ do not have direct pathways to $Y$ other than through $M$ and $H$, respectively.\n\nAnswer choices are independent; select all that are correct. Do not assume availability of interventional data. Base your reasoning on the structural equations, Mendelian assortment, and the definitions of instrumental variable assumptions, without appealing to any unmentioned shortcut formulas.",
            "solution": "The problem statement is a valid representation of a causal inference challenge in systems biomedicine. It is scientifically grounded, well-posed, objective, and internally consistent. It poses a non-trivial question regarding the estimation of causal effects from observational data in the presence of unmeasured confounding, a central problem in epidemiology and statistical genetics.\n\n### Analysis of Naive Regression Bias\n\nThe goal is to estimate the causal parameters $\\beta_M$ and $\\beta_H$ from the structural equation for the outcome $Y$:\n$$Y = \\beta_M M + \\beta_H H + \\beta_U U + \\varepsilon_Y$$\nA naive regression of $Y$ on $M$ alone, i.e., fitting $Y \\sim M$, would yield an estimated coefficient that converges to $\\frac{\\text{Cov}(Y, M)}{\\text{Var}(M)}$. Let's analyze this term. Assuming all variables are mean-centered for simplicity:\n$$ \\text{Cov}(Y, M) = \\text{Cov}(\\beta_M M + \\beta_H H + \\beta_U U + \\varepsilon_Y, M) $$\n$$ = \\beta_M \\text{Cov}(M, M) + \\beta_H \\text{Cov}(H, M) + \\beta_U \\text{Cov}(U, M) + \\text{Cov}(\\varepsilon_Y, M) $$\nGiven the structural models for $M$ and $H$:\n$$ M = \\alpha_{G_M} G_M + \\alpha_{U \\to M} U + \\varepsilon_M $$\n$$ H = \\alpha_{G_H} G_H + \\alpha_{U \\to H} U + \\varepsilon_H $$\nThe unmeasured factor $U$ is a common cause of $M$, $H$, and $Y$. From the equations, we can see that $U$ is correlated with $M$ (if $\\alpha_{U \\to M} \\neq 0$) and $H$ (if $\\alpha_{U \\to H} \\neq 0$). Thus, $\\text{Cov}(U, M)$ and $\\text{Cov}(H, M)$ (via the shared dependence on $U$) are generally non-zero.\nSpecifically, $\\text{Cov}(U, M) = \\alpha_{U \\to M} \\text{Var}(U)$ (assuming $U$ is uncorrelated with $G_M$ and $\\varepsilon_M$).\nThe regression coefficient from the naive model is:\n$$ \\frac{\\text{Cov}(Y, M)}{\\text{Var}(M)} = \\beta_M + \\beta_H \\frac{\\text{Cov}(H, M)}{\\text{Var}(M)} + \\beta_U \\frac{\\text{Cov}(U, M)}{\\text{Var}(M)} $$\nThis expression is biased for the true causal effect $\\beta_M$. The bias consists of two terms: one due to confounding from the parallel exposure $H$ which is itself affected by $U$ (path $M \\leftarrow U \\to H \\to Y$), and another due to direct confounding by $U$ (path $M \\leftarrow U \\to Y$). Because $U$ is unmeasured, this bias cannot be removed by simply including $U$ in a regression model. This is a classic example of omitted-variable bias.\n\n### Instrumental Variable (IV) Strategies\n\nTo overcome this bias, we can use genetic variants as instrumental variables. A valid instrument $G$ for an exposure $M$ must satisfy three core assumptions:\n1.  **Relevance (IV1):** $G$ must be associated with $M$. For $G_M$, this means $\\alpha_{G_M} \\neq 0$.\n2.  **Independence (IV2):** $G$ must be independent of all unmeasured confounders $U$ of the $M-Y$ relationship. Due to Mendelian assortment, this is plausible for germline variants with respect to environmental or behavioral confounders, i.e., $\\text{Cov}(G_M, U) = 0$.\n3.  **Exclusion Restriction (IV3):** $G$ affects $Y$ only through $M$. Any path from $G$ to $Y$ must pass through $M$.\n\nA crucial challenge, highlighted by the model, is that the instrument for one exposure might be correlated with the other exposure, violating the exclusion restriction. This is known as horizontal pleiotropy. For example, if we use $G_M$ as an instrument for $M$, the IV estimator for $\\beta_M$ is $\\frac{\\text{Cov}(G_M, Y)}{\\text{Cov}(G_M, M)}$.\n$$ \\text{Cov}(G_M, Y) = \\text{Cov}(G_M, \\beta_M M + \\beta_H H + \\beta_U U) = \\beta_M \\text{Cov}(G_M, M) + \\beta_H \\text{Cov}(G_M, H) $$\nThe IV estimator is $\\beta_M + \\beta_H \\frac{\\text{Cov}(G_M, H)}{\\text{Cov}(G_M, M)}$. It is biased unless $\\beta_H=0$ or $\\text{Cov}(G_M, H)=0$. The term $\\text{Cov}(G_M, H)$ will be non-zero if $G_M$ pleiotropically affects $H$ or is in linkage disequilibrium (LD) with $G_H$.\n\n### Evaluation of Options\n\n**A. Use a single cis-meQTL $G_M$ as an instrument for $M$ ...**\nThis option presents a rigorous workflow for single-instrument Mendelian Randomization (MR). Checking for a strong instrument ($F$-statistic $> 10$) validates the Relevance assumption (IV1) and mitigates weak instrument bias. Checking for association with proxies for $U$ is a necessary (though incomplete) test of the Independence assumption (IV2). Crucially, using fine-mapping and colocalization to confirm a shared causal variant for the $G_M-M$ and $G_M-Y$ associations is a state-of-the-art method to strengthen the evidence for the Exclusion Restriction (IV3) and rule out confounding by LD. Finally, acknowledging the need for sensitivity analyses for residual horizontal pleiotropy demonstrates a methodologically sound and cautious approach.\nVerdict: **Correct**.\n\n**B. Use a trans-expression quantitative trait locus (trans-eQTL) ...**\nThis proposal is fundamentally flawed. A `trans-eQTL` that broadly influences multiple genes is, by definition, highly pleiotropic. The exclusion restriction (IV3) requires the instrument to affect the outcome *solely* through the specified exposure ($H$). An instrument with widespread effects violates this assumption maximally, as it creates numerous pathways to the outcome ($Y$) that do not pass through $H$. The claim that this \"minimizes violation of the exclusion restriction by averaging effects\" is baseless; widespread pleiotropy is the primary threat to the validity of an MR study, not a feature to be desired. Furthermore, `trans` effects are typically much weaker than `cis` effects, so such a variant would likely be a weak instrument, leading to substantial bias.\nVerdict: **Incorrect**.\n\n**C. Adjust for measured confounders in a multiple regression...**\nThis statement demonstrates a fundamental misunderstanding of confounding bias. Confounding by unmeasured variables ($U$) is a source of systematic error (bias), not random error (variance). Increasing the sample size $n$ reduces variance and increases the precision of an estimate, but it does not reduce bias. An estimator subject to confounding is inconsistent; as $n \\to \\infty$, it converges to a wrong value, not the true causal effect. Given that $U$ is defined to include potent factors like smoking and immune cell composition, the residual unmeasured confounding is expected to be substantial, not negligible, regardless of sample size.\nVerdict: **Incorrect**.\n\n**D. Implement two-sample Mendelian randomization combining summary statistics ...**\nThis option describes a sophisticated and valid two-sample MR study design. Using summary statistics ($\\widehat{\\beta}_{YG}$ and $\\widehat{\\beta}_{MG}$) from large-scale GWAS and EWAS is a powerful and efficient approach. The proposed validation steps are critical and appropriate: colocalization addresses confounding by LD at the instrument locus; the Steiger directionality test helps confirm the assumed causal direction ($G_M \\to M \\to Y$) and guards against reverse causation ($G_M \\to Y \\to M$); and restricting to ancestrally matched samples mitigates bias from population stratification. This constitutes a robust, state-of-the-art MR pipeline.\nVerdict: **Correct**.\n\n**E. Construct a polygenic risk score for $Y$ and use it as an instrument for $M$ ...**\nThis strategy is invalid. A polygenic risk score (PRS) for the outcome $Y$ is constructed from a multitude of genetic variants known to be associated with $Y$. To serve as a valid instrument for $M$, this PRS would need to satisfy the exclusion restriction: it must influence $Y$ *only* through $M$. By its very construction, a PRS for $Y$ includes variants that influence $Y$ through myriad biological pathways, most of which will not involve the specific epigenetic mark $M$. This represents a massive violation of the exclusion restriction due to pervasive horizontal pleiotropy. While the variants are germline, satisfying independence from environmental confounders (IV2), the violation of the exclusion restriction (IV3) makes the instrument utterly unsuitable for estimating the causal effect of $M$.\nVerdict: **Incorrect**.\n\n**F. Fit a multivariable Mendelian randomization using $G_M$ as an instrument for $M$ and $G_H$ as an instrument for $H$ ...**\nThis is an advanced and highly appropriate strategy for the given problem. The structural model explicitly includes two exposures, $M$ and $H$, which are likely to be correlated and whose genetic influences may be linked. Multivariable MR (MVMR) is specifically designed to address this scenario. By using instruments for both exposures ($G_M$ and $G_H$), MVMR can simultaneously estimate the direct causal effects of $M$ on $Y$ ($\\beta_M$) and $H$ on $Y$ ($\\beta_H$), while accounting for the correlation between the instruments (e.g., LD) and the correlation between the exposures. The described diagnostics—conditional $F$-statistics for instrument strength and multivariable MR-Egger for pleiotropy—are the correct, state-of-the-art tools for validating an MVMR analysis. This approach correctly addresses the pleiotropic confounding path ($G_M \\to H \\to Y$ or $G_M \\leftrightarrow G_H \\to H \\to Y$) that would bias a standard single-exposure MR.\nVerdict: **Correct**.",
            "answer": "$$\\boxed{ADF}$$"
        }
    ]
}